Helen Foundation introduces Microdose Therapy
Microdose Therapy by the Helen Foundation teaches patient self-administration of hydrocortisone to treat cortisone-responsive chronic pain conditions. This method results in dramatic relief from symptoms and virtually eliminates side effects. We have successfully treated chronic pain for more than 10 years and have done so with phenomenal results, without the use of narcotic medications.
Conditions in which corticosteroid use are indicated include: endocrine and rheumatic disorders, collagen and dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic and neoplastic diseases, edematous states, gastrointestinal diseases, to name a few. The “Dosage and Administration” used for patient self-administration of hydrocortisone is within the scope of accepted use described in the PDR and supported in peer-reviewed published medical literature.
Microdose Therapy teaches patients to quantify their symptoms daily using a simple, comprehensive system that assists in precise treatment decision making and tracking of symptom response.
We trust you will find this sample of statistics using our protocol impressive:
|Disease||Patients||Average Relief, %|
|Chronic Fatigue Syndrome||23||56|
|Irritable bowel syndrome||20||70|
Physicians and patients alike are often frustrated with the inadequacy of common treatment options available for these conditions and other chronic debilitating conditions. The Helen Foundation recommends that you try patient self-administration of hydrocortisone for your most difficult cases.
We provide the protocol and treatment instructions. We work with the physician and patient, carefully track their response to therapy and give the recommended dosages individualized for each. In addition, we perform the time-consuming, one-year patient education.